• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病和认知的血液生物标志物:文献综述。

Blood Biomarkers of Alzheimer's Disease and Cognition: A Literature Review.

机构信息

Hospital del Mar Medical Research Institute, 08003 Barcelona, Spain.

Neurology Department, Hospital del Mar, 08003 Barcelona, Spain.

出版信息

Biomolecules. 2024 Jan 11;14(1):93. doi: 10.3390/biom14010093.

DOI:10.3390/biom14010093
PMID:38254693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10813472/
Abstract

Recent advances in blood-based biomarkers of Alzheimer's Disease (AD) show great promise for clinical applications, offering a less invasive alternative to current cerebrospinal fluid (CSF) measures. However, the relationships between these biomarkers and specific cognitive functions, as well as their utility in predicting longitudinal cognitive decline, are not yet fully understood. This descriptive review surveys the literature from 2018 to 2023, focusing on the associations of amyloid-β (Aβ), Total Tau (t-Tau), Phosphorylated Tau (p-Tau), Neurofilament Light (NfL), and Glial Fibrillary Acidic Protein (GFAP) with cognitive measures. The reviewed studies are heterogeneous, varying in design and population (cognitively unimpaired, cognitively impaired, or mixed populations), and show results that are sometimes conflicting. Generally, cognition positively correlates with Aβ levels, especially when evaluated through the Aβ/Aβ ratio. In contrast, t-Tau, p-Tau, Nfl, and GFAP levels typically show a negative correlation with cognitive performance. While p-Tau measures generally exhibit stronger associations with cognitive functions compared to other biomarkers, no single blood marker has emerged as being predominantly linked to a specific cognitive domain. These findings contribute to our understanding of the complex relationship between blood biomarkers and cognitive performance and underscore their potential utility in clinical assessments of cognition.

摘要

近年来,阿尔茨海默病(AD)的基于血液生物标志物的研究进展显示出在临床应用方面的巨大潜力,为当前的脑脊液(CSF)测量提供了一种侵入性较小的替代方法。然而,这些生物标志物与特定认知功能之间的关系,以及它们在预测纵向认知下降方面的效用,尚未完全理解。本描述性综述调查了 2018 年至 2023 年的文献,重点关注淀粉样蛋白-β(Aβ)、总 Tau(t-Tau)、磷酸化 Tau(p-Tau)、神经丝轻链(NfL)和神经胶质纤维酸性蛋白(GFAP)与认知测量的关联。综述的研究具有异质性,设计和人群(认知正常、认知受损或混合人群)各不相同,结果有时相互矛盾。一般来说,认知与 Aβ 水平呈正相关,尤其是通过 Aβ/Aβ 比值进行评估时。相比之下,t-Tau、p-Tau、Nfl 和 GFAP 水平通常与认知表现呈负相关。虽然 p-Tau 测量值通常与认知功能的相关性比其他生物标志物更强,但没有一种血液标志物被证明主要与特定认知领域相关。这些发现有助于我们理解血液生物标志物与认知表现之间的复杂关系,并强调它们在认知临床评估中的潜在效用。

相似文献

1
Blood Biomarkers of Alzheimer's Disease and Cognition: A Literature Review.阿尔茨海默病和认知的血液生物标志物:文献综述。
Biomolecules. 2024 Jan 11;14(1):93. doi: 10.3390/biom14010093.
2
Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.阿尔茨海默病连续体中的血浆 Aβ42/40 比值、p-tau181、GFAP 和 NfL:AIBL 队列的横断面和纵向研究。
Alzheimers Dement. 2023 Apr;19(4):1117-1134. doi: 10.1002/alz.12724. Epub 2022 Jul 21.
3
Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.阿尔茨海默病风险加权多基因风险评分预测临床前阿尔茨海默病认知下降率的效用:一项前瞻性纵向研究。
J Alzheimers Dis. 2018;66(3):1193-1211. doi: 10.3233/JAD-180713.
4
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.阿尔茨海默病患者纵向血浆神经丝轻链与神经退行性变的关系。
JAMA Neurol. 2019 Jul 1;76(7):791-799. doi: 10.1001/jamaneurol.2019.0765.
5
The dynamics of plasma biomarkers across the Alzheimer's continuum.阿尔茨海默病连续体中血浆生物标志物的动态变化。
Alzheimers Res Ther. 2023 Feb 8;15(1):31. doi: 10.1186/s13195-023-01174-0.
6
Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients.在客观定义的轻度认知障碍患者中,血浆磷酸化 tau181 和神经丝轻链与脑淀粉样蛋白负担和认知的相关性。
CNS Neurosci Ther. 2022 Dec;28(12):2195-2205. doi: 10.1111/cns.13962. Epub 2022 Sep 8.
7
Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions.胶质和神经元退行性标志物与阿尔茨海默病脑脊液特征和认知功能的关联。
Alzheimers Res Ther. 2020 Aug 4;12(1):92. doi: 10.1186/s13195-020-00657-8.
8
Age, vascular disease, and Alzheimer's disease pathologies in amyloid negative elderly adults.在无淀粉样蛋白的老年人群中,年龄、血管疾病和阿尔茨海默病病理。
Alzheimers Res Ther. 2021 Oct 15;13(1):174. doi: 10.1186/s13195-021-00913-5.
9
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.血浆神经丝轻链与阿尔茨海默病影像学生物标志物的阶段特异性关联。
Brain. 2020 Dec 1;143(12):3793-3804. doi: 10.1093/brain/awaa342.
10
Relationship between topological efficiency of white matter structural connectome and plasma biomarkers across the Alzheimer's disease continuum.白质结构连接组拓扑效率与阿尔茨海默病连续体中血浆生物标志物的关系。
Hum Brain Mapp. 2024 Jan;45(1):e26566. doi: 10.1002/hbm.26566.

引用本文的文献

1
Reproductive health history and later life cognition in African Caribbean women.非洲加勒比裔女性的生殖健康史与晚年认知
Alzheimers Dement. 2025 Aug;21(8):e70547. doi: 10.1002/alz.70547.
2
Combinatorial targeting of NMDARs and 5-HTRs exerts beneficial effects in a mouse model of Alzheimer's disease.对N-甲基-D-天冬氨酸受体(NMDARs)和5-羟色胺受体(5-HTRs)进行组合靶向治疗可在阿尔茨海默病小鼠模型中产生有益效果。
Alzheimers Res Ther. 2025 Jul 15;17(1):160. doi: 10.1186/s13195-025-01804-9.
3
Evaluating the safety and feasibility of remote ischemic conditioning for slowing cognitive decline in mild Alzheimer's dementia.评估远程缺血预处理对减缓轻度阿尔茨海默病性痴呆认知衰退的安全性和可行性。
Front Neurol. 2025 Jun 24;16:1592829. doi: 10.3389/fneur.2025.1592829. eCollection 2025.
4
Factor analysis of multimodal MRI, biofluid, and vascular biomarkers reveals latent constructs of brain health.多模态磁共振成像、生物流体和血管生物标志物的因子分析揭示了大脑健康的潜在结构。
Geroscience. 2025 Jul 8. doi: 10.1007/s11357-025-01771-x.
5
Kidney function is associated with plasma ATN biomarkers among Hispanics/Latinos: SOL-INCA and HCHS/SOL results.西班牙裔/拉丁裔人群的肾功能与血浆急性肾损伤生物标志物相关:SOL-INCA和HCHS/SOL研究结果
Alzheimers Res Ther. 2025 Jun 19;17(1):137. doi: 10.1186/s13195-025-01786-8.
6
Machine learning based prediction of cognitive metrics using major biomarkers in SuperAgers.利用超级长寿者的主要生物标志物,基于机器学习对认知指标进行预测。
Sci Rep. 2025 May 28;15(1):18735. doi: 10.1038/s41598-025-01477-2.
7
Blood-Based β-Amyloid and Phosphorylated Tau (p-Tau) Biomarkers in Alzheimer's Disease: A Systematic Review of Their Diagnostic Potential.阿尔茨海默病中基于血液的β-淀粉样蛋白和磷酸化tau蛋白(p-Tau)生物标志物:对其诊断潜力的系统评价
Cureus. 2025 Mar 1;17(3):e79881. doi: 10.7759/cureus.79881. eCollection 2025 Mar.
8
Associations between the logical memory test story recall metrics and plasma biomarkers for Alzheimer's disease in individuals free of dementia.无痴呆个体中阿尔茨海默病的逻辑记忆测试故事回忆指标与血浆生物标志物之间的关联。
Clin Neuropsychol. 2025 Mar 20:1-20. doi: 10.1080/13854046.2025.2481119.
9
Blood biomarkers differentiate AD-related versus non-AD-related cognitive deficits.血液生物标志物可区分与阿尔茨海默病相关和非阿尔茨海默病相关的认知缺陷。
Alzheimers Dement. 2025 Mar;21(3):e14619. doi: 10.1002/alz.14619.
10
Electrochemical Technology for the Detection of Tau Proteins as a Biomarker of Alzheimer's Disease in Blood.用于检测血液中作为阿尔茨海默病生物标志物的 Tau 蛋白的电化学技术
Biosensors (Basel). 2025 Feb 4;15(2):85. doi: 10.3390/bios15020085.

本文引用的文献

1
Plasma phosphorylated tau-217 exhibits sex-specific prognostication of cognitive decline and brain atrophy in cognitively unimpaired adults.血浆磷酸化 tau-217 在认知正常成年人中具有性别特异性的认知下降和脑萎缩预后价值。
Alzheimers Dement. 2024 Jan;20(1):376-387. doi: 10.1002/alz.13454. Epub 2023 Aug 28.
2
Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study.基线生物标志物对主观认知衰退认知轨迹的影响:CoSCo 前瞻性队列研究。
Alzheimers Res Ther. 2023 Aug 7;15(1):132. doi: 10.1186/s13195-023-01273-y.
3
Plasma neurofilament light chain in relation to 10-year change in cognition and neuroimaging markers: a population-based study.血浆神经丝轻链与认知和神经影像学标志物 10 年变化的关系:一项基于人群的研究。
Geroscience. 2024 Feb;46(1):57-70. doi: 10.1007/s11357-023-00876-5. Epub 2023 Aug 3.
4
The performance of plasma phosphorylated tau231 in detecting Alzheimer's disease: A systematic review with meta-analysis.血浆磷酸化tau231在检测阿尔茨海默病中的表现:一项系统评价与荟萃分析
Eur J Neurosci. 2023 Aug;58(4):3132-3149. doi: 10.1111/ejn.16085. Epub 2023 Jul 27.
5
Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease.在认知功能正常的老年人中,比较 APOE4 相关阿尔茨海默病风险水平为三级的患者血浆 p-tau181、p-tau231 和神经胶质纤维酸性蛋白。
Neurobiol Dis. 2023 Jul;183:106175. doi: 10.1016/j.nbd.2023.106175. Epub 2023 Jun 1.
6
Plasma Biomarkers of Alzheimer's Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice.阿尔茨海默病的血浆生物标志物:现有检测方法、最新进展及对临床实践的意义综述
J Alzheimers Dis Rep. 2023 May 3;7(1):355-380. doi: 10.3233/ADR-230029. eCollection 2023.
7
Predictive blood biomarkers and brain changes associated with age-related cognitive decline.与年龄相关的认知衰退相关的预测性血液生物标志物和脑部变化。
Brain Commun. 2023 Apr 6;5(3):fcad113. doi: 10.1093/braincomms/fcad113. eCollection 2023.
8
APOE differentially moderates cerebrospinal fluid and plasma phosphorylated tau181 associations with multi-domain cognition.载脂蛋白 E 差异调节脑脊液和血浆磷酸化 tau181 与多领域认知的关联。
Neurobiol Aging. 2023 May;125:1-8. doi: 10.1016/j.neurobiolaging.2022.10.016. Epub 2023 Jan 18.
9
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.使用血浆生物标志物预测临床前阿尔茨海默病的纵向认知下降。
JAMA Neurol. 2023 Apr 1;80(4):360-369. doi: 10.1001/jamaneurol.2022.5272.
10
Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer's disease in individuals with subjective cognitive decline.一种用于检测阿尔茨海默病个体主观认知下降中早期变化的无抗体测定法对血浆 Aβ42/Aβ40 的临床性能。
Alzheimers Res Ther. 2023 Jan 5;15(1):2. doi: 10.1186/s13195-022-01143-z.